Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Buy
60
HALO Quote, Financials, Valuation and Earnings
Last price:
$53.88
Seasonality move
:
1.46%
Day range:
$53.55 - $54.40
52-week range:
$42.01 - $70.51
Dividend yield:
0%
P/E ratio:
14.34x
P/S ratio:
6.40x
P/B ratio:
13.78x
Volume:
1.4M
Avg. volume:
2.9M
1-year change:
8.93%
Market cap:
$6.6B
Revenue:
$1B
EPS (TTM):
$3.76
Earnings Data
Next earnings date for HALO
Aug 06
2025
Most recent earnings per share
$0.93
Missed by $0.01
(May 6/2025)
Consensus Estimate
$0.94
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HALO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/06/2025 | Q2 | $282.7M | -- | -- | $1.20 | -- |
| 05/06/2025 | Q1 | $230.2M | $264.9M | $0.93 | $0.94 | -$0.01 |
| 02/18/2025 | Q4 | $285.7M | $298M | $1.06 | $1.16 | -$0.10 |
| 10/31/2024 | Q3 | $252.2M | $290.1M | $1.05 | $1.00 | $0.05 |
| 08/06/2024 | Q2 | $204.9M | $231.4M | $0.72 | $0.76 | -$0.04 |
| 05/07/2024 | Q1 | $199.6M | $195.9M | $0.60 | $0.70 | -$0.10 |
| 02/20/2024 | Q4 | $231.1M | $230M | $0.65 | $0.83 | -$0.18 |
| 11/06/2023 | Q3 | -- | -- | $0.61 | $0.71 | -$0.10 |
| 08/08/2023 | Q2 | -- | -- | $0.56 | $0.64 | -$0.08 |
| 05/09/2023 | Q1 | -- | -- | $0.29 | $0.48 | -$0.19 |
| 02/21/2023 | Q4 | -- | -- | $0.42 | $0.47 | -$0.05 |
| 11/08/2022 | Q3 | -- | -- | $0.44 | $0.51 | -$0.07 |
| 08/09/2022 | Q2 | -- | -- | $0.16 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | $0.43 | -- | -- |
| 02/22/2022 | Q4 | -- | -- | $0.46 | -- | -- |
| 11/02/2021 | Q3 | -- | -- | $1.48 | -- | -- |
| 08/09/2021 | Q2 | -- | -- | $0.62 | -- | -- |
| 05/10/2021 | Q1 | -- | -- | $0.19 | -- | -- |
| 02/23/2021 | Q4 | -- | -- | $0.50 | -- | -- |
| 11/02/2020 | Q3 | -- | -- | $0.25 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | $0.19 | -- | -- |
| 05/11/2020 | Q1 | -- | -- | -$0.04 | -- | -- |
| 02/24/2020 | Q4 | -- | -- | -$0.24 | -- | -- |
| 11/12/2019 | Q3 | -- | -- | -$0.17 | -- | -- |
| 08/06/2019 | Q2 | -- | -- | -$0.10 | -- | -- |
| 05/07/2019 | Q1 | -- | -- | $0.01 | -- | -- |
| 02/21/2019 | Q4 | -- | -- | -$0.01 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | -$0.16 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | -$0.19 | -- | -- |
| 02/20/2018 | Q4 | -- | -- | $0.85 | -- | -- |
| 11/07/2017 | Q3 | -- | -- | $0.02 | -- | -- |
| 08/08/2017 | Q2 | -- | -- | -$0.23 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -$0.26 | -- | -- |
| 02/28/2017 | Q4 | -- | -- | -$0.21 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.23 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.21 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.16 | -- | -- |
| 02/29/2016 | Q4 | -- | -- | $0.03 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/10/2015 | Q2 | -- | -- | $0.02 | -- | -- |
Halozyme Therapeutics Earnings Questions
-
How Much did Halozyme Therapeutics Generate in Revenue Last Quarter?
Halozyme Therapeutics reported $264.9M worth of top line sales in its most recent quarter.
-
Did Halozyme Therapeutics Beat Earnings Last Quarter?
Halozyme Therapeutics announced earnings per share of $0.93 which represents a miss of analyst forecast a $0.94 per share.
-
Is Halozyme Therapeutics Profitable?
Halozyme Therapeutics reported $216.5M that represents $1.71 per share over the last quarter.
-
What is the Analyst Consensus for Halozyme Therapeutics EPS Next Year?
Halozyme Therapeutics's earnings are forecast to grow from $3.43 per share to $4.13 per share next year representing an increase of 54.37%.
-
When is Halozyme Therapeutics's Earnings Date?
Halozyme Therapeutics's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 18.38% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 1.73% over the past day.
Sell
43
TNXP alert for Jun 17
Tonix Pharmaceuticals Holding [TNXP] is down 2.16% over the past day.
